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ABSTRACT: The synthesis and spectroscopic characterization of two new, cell-trappable fluorescent 
probes for Zn(II) are presented. These probes, 2-(4,5-bis((6-(2-ethoxy-2-oxoethoxy)quinolin-8-
yl)amino)methyl)-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid (QZ2E) and 2,2′-((8,8′-(((9-(2-
carboxyphenyl)-6-hydroxy-3-oxo-3H-xanthene-4,5-diyl)bis(methyl-ene))bis(azanediyl)bis(quinolin-8,6-
diyl)}bis(oxy))diacetic acid (QZ2A), are poorly emissive in the off-state, but exhibit dramatic increases 
in fluorescence upon Zn(II) binding (120 ± 10-fold for QZ2E, 30 ± 7-fold for QZ2A). This binding is 
selective for Zn(II) over other biologically relevant metal cations, toxic heavy metals, and most first-row 
transition metals, and is of appropriate affinity (Kd1 (QZ2E) = 150 ± 100 µM, Kd2 (QZ2E) = 3.5 ± 0.1 
mM, Kd1 (QZ2A) = 220 ± 30 µM, Kd2 (QZ2A) = 160 ± 80 µM, Kd3 (QZ2A) = 9 ± 6 µM) to reversibly 
bind Zn(II) at physiological levels. In live cells, QZ2E localizes to the Gogli apparatus where it can de-
tect Zn(II). It is cell membrane permeable until cleavage of its ester groups by intracellular esterases 
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produces QZ2A, a negatively charged acid form that cannot cross the cell membrane. 
KEYWORDS: Zinc, cell-trappable sensor, fluorescence, binding constant 
Introduction 
Zinc is a ubiquitous and essential metal in biology. It is both tightly associated with proteins, where it 
plays structural and catalytic roles,1 and loosely bound in pools of so-called “mobile zinc.”2 The latter 
occur in abundance in certain regions of the body, including the hippocampus3 and olfactory bulb4 in the 
brain, the mitochondria of the prostate,5,6 and the pancreas,7 where release of Zn(II) plays an important 
role in physiological signaling and other functions. As for any signaling molecule, maintaining homeo-
stasis is critical to proper function, and zinc levels are highly regulated by transporters2,8,9 and zinc-
binding proteins, such as metallothionein.10,11 Disruption of Zn(II) homeostasis has been associated with 
several pathologies, including ischemia,12 Alzheimer’s disease,13,14 and prostate cancer.15,16 
To understand the biological roles of mobile Zn(II) it is desirable to have tools for its detection in 
vivo.17-21 Although many methods are available for sensing metal ions, fluorescence detection by mi-
croscopy has proved to be an invaluable technique for non-invasive imaging of mobile Zn(II). Fluores-
cent probes can be designed to be biologically compatible, that is, water-soluble, cell-membrane perme-
able, non-toxic, and excitable at low-energy wavelengths that do not induce interfering autofluorescence 
or harm the cell. Their photophysical properties can be tuned such that large differences occur in lumi-
nescence for the metal-free and metal-bound states, through changes in intensity and/or wavelength. 
Sensor characteristics such as binding affinity can be adjusted to match the physiological concentration 
of the analyte of interest and, in the case of metal ion sensing, the chelating group can be chosen to im-
part selectivity to the probe. 
Many such Zn(II)-selective sensors have been designed and utilized for both ex vivo and in vivo im-
aging. Fig. 1 portrays a selection of symmetrical, fluorescein-based probes of this kind developed in our 
laboratory.22-31 Fluorescein is an ideal reporter because it is biologically compatible, very bright in the 
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on-state (φ = 0.95 in 0.1 N NaOH),32 and compatible with most fluorescent microscopes. The pH de-
pendence of fluorescein can be modified such that proton-induced fluorescence enhancement of a probe 
is minimized at physiological pH.23,27,33,34 Symmetrical sensors tend to have lower extinction coefficients 
than their asymmetrical counterparts, thereby lowering fluorescence emission in the metal-free state and 
increasing the effective dynamic range.23,25 
One of the symmetrical probes illustrated in Fig. 1, QZ2,25 displays particularly interesting sensing 
characteristics by comparison to the first generation Zinpyr (or ZP) family of probes.22,23,28-31,35-39 For ex-
ample, QZ2 has a much lower affinity for Zn(II) (Kd1 ~ mid-micromolar) than ZP1 (Kd1 ~ picomolar), 
and can therefore detect higher concentrations of mobile Zn(II) reversibly and without probe saturation. 
It also has a larger dynamic range (~ 150-fold turn on) than any of the ZP-type probes, which is benefi-
cial for in vivo imaging, where poor signal-to-noise ratios can limit data interpretation. One limitation of  
Figure 1. Select symmetrical, fluorescein-based Zn(II) probes. 
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QZ2 is that it is not cell-trappable. Other similar quinoline-derivatized fluorescein probes, such as the 
NO sensor CuFL1,40,41 readily diffuse out of cells after loading under continual perfusion of media. Be-
cause media flow is a requirement for many biological imaging experiments, a cell-trappable version of 
QZ2 would render it useful for more diverse sensing applications.  
Herein we report the synthesis, photophysical characterization, and live-cell imaging of the desired 
new probe for Zn(II), QZ2E, which employs the ester/acid strategy for cell-trappability, as well as its 
cell-impermeable acid counterpart, QZ2A. QZ2E and QZ2A display dramatic fluorescence enhance-
ments in the presence of excess Zn(II), which are selective for the metal over other biologically relevant 
alkali and alkaline earth metal ions, toxic heavy metal ions, and most first row transition metal ions. The 
binding of Zn(II) by QZ2E and QZ2A is weak with Kd values ranging from micromolar to millimolar, 
making the sensors suitable for detecting mobile Zn(II) at high physiological concentrations. 
 
Experimental Section 
Synthetic Materials and Methods. 4′,5′-Fluoresceindicarboxaldehyde22 and ethylenediamine 
tetraacetate ethyl ester (EDTA-(Et)4)42 were prepared by previously reported procedures. All other 
chemicals were used as received. Silica gel (SiliaFlash F60, Silicycle, 230-400 mesh) was used for col-
umn chromatography. Thin-layer chromatography (TLC) was performed on EMD Chemicals F254 sil-
ica gel-60 plates (1 mm thickness), and viewed by either UV light or ninhydrin staining. 1H and 13C{1H} 
NMR spectra were obtained on either a Varian 300 MHz or 500 MHz spectrometer. Chemical shifts are 
reported in parts per million (δ) and are referenced to residual protic solvent resonances. The following 
abbreviations are used in describing NMR couplings: (s) singlet, (d) doublet, (dd) doublet of doublets, 
(t) triplet, (q) quartet, (m) multiplet. High-resolution mass spectra were measured by staff at the MIT 
Department of Chemistry Instrumentation Facility (DCIF).  
6-Hydroxy-8-nitroquinoline (1). 4-Amino-3-nitrophenol (5.00 g, 32.4 mmol) was suspended at 95 
OC in 37% hydrochloric acid (35 mL) and 85% phosphoric acid (15 mL). Acrolein (2.4 mL, 36 mmol) 
  
  5 
was added dropwise and the reaction mixture was stirred while heating for 4 h, during which time it 
changed color from yellow to orange to dark red. The reaction mixture was cooled, filtered, and washed 
with water. Ammonium hydroxide (28%, 50 mL) was added to the filtrate and the resulting red precipi-
tate was filtered and washed with water to yield pure product (1.11 g, 18%). TLC Rf = 0.68 (silica, 9:1 
CH2Cl2:CH3OH); mp: 162 – 163 oC (dec); 1H NMR (DMSO-d6, 300 MHz) δ: 7.45 (1H, d, J = 2.7 Hz), 
7.58 (1H, dd, J = 8.4 Hz, 4.2 Hz), 7.80 (1H, d, 2.7 Hz), 8.35 (1H, dd, J = 8.4 Hz, 1.2 Hz), 8.78 (1H, dd, 
J = 4.2 Hz, 1.8 Hz); 13C{1H} NMR (DMSO-d6, 125 MHz) δ: 112.34, 115.45, 123.19, 129.82, 133.50, 
134.76, 148.63, 149.34, 154.42; HRMS (m/z): [M + H]+ calcd 191.0451, found 191.0450. 
Ethyl[(8-aminoquinolin-6-yloxy)acetate] (2). To a solution of 6-hydroxy-8-nitroquinoline (1, 234 
mg, 1.23 mmol) in ethanol (10 mL) was added ethylbromoacetate (400 µL, 3.6 mmol) and N,N-
diisopropylethylamine (650 µL, 3.7 mmol) and the reaction was heated to reflux for 24 h. The reaction 
was then cooled and the solvent removed. The resultant crude product was taken up in fresh ethanol (25 
mL) containing 10% palladium on carbon (203 mg) and purged with N2 for 15 min, after which an at-
mosphere of H2 was applied and the reaction was stirred at room temperature for 16 h. The resulting so-
lution was then purged with N2, filtered, and the solvent was removed. The dark brown solid was puri-
fied by column chromatography on silica using 3:1 hexanes:ethyl acetate as the eluant to afford a pure, 
light brown solid (227 mg, 75%). TLC Rf = 0.20 (silica, 1:1 Hex:EtOAc); mp: 92 – 94 oC; 1H NMR 
(CD2Cl2, 300 MHz) δ: 1.29 (3H, t, J = 7.2 Hz), 4.26 (2H, q, J = 7.2 Hz), 4.69 (2H, s), 5.08 (2H, broad 
s), 6.39 (1H, d, J = 2.7 Hz), 6.61 (1H, d, J = 2.4 Hz), 7.33 (1H, dd, J = 8.4, 4.2 Hz), 7.95 (1H, dd, J = 
8.4 Hz, 1.5 Hz), 8.59 (1H, dd, J = 4.2 Hz, 1.5 Hz; 13C{1H} NMR (CD2Cl2, 125 MHz) δ: 14.51, 61.84, 
65.78, 95.62, 101.40, 122.51, 130.12, 135.34, 135.97, 145.97, 146.16, 157.58, 169.22; HRMS (m/z): [M 
+ H]+ calcd 247.1077, found 247.1079. 
    2-(4,5-Bis(((6-(2-ethoxy-2-oxoethoxy)quinolin-8-yl)amino)methyl)-6-hydroxy-3-oxo-3H-xanthen-
9-yl)benzoic acid (QZ2E, 3). 4′,5′-Fluoresceindicarboxaldehyde (43.9 mg, 113 μmol) and ethyl[(8-
aminoquinolin-6-yloxy)acetate] (2, 54.8 mg, 223 μmol) were suspended in methanol (5 mL) and stirred 
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 at room temperature for 1 h. The dark red suspension was cooled to 0 oC and sodium borohydride (21.5 
mg, 568 μmol) was added. The reaction clarified to a dark red solution, which was stirred for 1 h as it 
warmed to room temperature. The reaction solution was quenched with water (5 mL) and the methanol 
was removed under reduced pressure. The aqueous phase was extracted with 5 x 10 mL of dichloro-
methane and the combined extracts were dried over MgSO4, filtered, and the solvent was removed. The 
resulting residue was purified by column chromatography on silica (gradient from 99:1 CH2Cl2:CH3OH 
to 19:1 CH2Cl2:CH3OH) to afford a dark red solid (25.6 mg, 27%). TLC Rf = 0.67 (silica,); mp: 148 – 
149 oC; 1H NMR (DMSO-d6, 500 MHz) δ: 1.19 (6H, t, J = 4.2 Hz), 4.16 (4H, q, J = 8.4 Hz, 4.2 Hz), 
4.75 (4H, s), 4.79 (4H, d, J = 3.6 Hz), 6.40 (2H, d, J = 1.5 Hz), 6.53 (2H, d, J = 5.4 Hz), 6.66 (2H, d, J = 
1.5 Hz), 6.71 (2H, d, J = 5.4 Hz), 6.77 (2H, t, J = 3.3 Hz), 7.34 (1H, d, J = 4.5 Hz), 7.37 (2H, dd, J = 4.8 
Hz, 2.4 Hz), 7.74 (2H, dt, J = 12 Hz, 4.2 Hz), 7.98 (1H, d, J = 4.5 Hz), 8.02 (2H, d, J = 4.8 Hz), 8.48 
(2H, d, J = 2.4 Hz); 13C{1H} NMR (DMSO-d6, 125 MHz) δ: 13.98, 14.13, 60.62, 64.61, 77.13, 83.42, 
93.18, 93.38, 96.26, 96.43, 109.90, 111.96, 122.14, 124.66, 126.31, 127.05, 127.73, 129.13, 130.14, 
134.65, 134.87, 145.28, 150.49, 152.08, 157.19, 157.56, 168.55, 168.61; HRMS (m/z): [M + Na]+ calcd, 
871.2586, found 871.2570. 
Synthesis of 2,2′-((8,8′-(((9-(2-carboxyphenyl)-6-hydroxy-3-oxo-3H-xanthene-4,5-diyl)bis(methyl-
ene))bis(azanediyl))bis(quinolin-8,6-diyl))bis(oxy))diacetic acid (QZ2A, 4). QZ2E (121.9 mg, 144 
μmol) was dissolved in aqueous sodium hydroxide (0.5 N, 15 mL) and methanol (5 mL) and heated to 
90 oC for 12 h. The solution was cooled to room temperature and the pH was adjusted with concentrated 
hydrochloric acid until an orange precipitate formed. The solid was filtered, washed with water, and 
dried to yield the product (77.6 mg, 68%). TLC Rf = 0.63 (silica, 100% CH3OH); mp: 139 – 141 oC 
(dec); 1H NMR (DMSO-d6, 300 MHz) δ: 4.62 (4H, s), 4.71 (4H, s), 6.46 (2H, s), 6.50 (2H, s), 6.59 (2H, 
d, J = 8.7 Hz), 6.75 (2H, d, J = 8.4 Hz), 7.39 – 7.42 (3H, m), 7.70 – 7.82 (2H, m), 8.00 (2H, d, J = 7.2 
Hz), 8.17 (2H, d, J = 7.8 Hz), 8.44 (2H, d, J = 3.9 Hz), 10.55 (2H, broad s); 13C{1H} NMR (DMSO-d6, 
125 MHz) δ: 36.40, 64.51, 93.39, 93.76, 98.31, 109.80, 111.22, 112.27, 121.85, 122.20, 124.33, 124.70, 
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126.10, 127.59, 127.91, 129.70, 130.16, 130.37, 135.62, 142.83, 143.67, 150.61, 152.52, 157.75, 
168.78, 169.96; HRMS (m/z): [M – H]— calcd 791.1995, found 791.1994. 
Spectroscopic Materials and Methods. Piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) was pur-
chased from Calbiochem. Potassium chloride (99.999%) was obtained from Aldrich. Buffer solutions 
(50 mM PIPES, 100 mM KCl, pH 7) were prepared in Millipore water, chelexed, filtered, and used for 
all spectroscopic studies. Zinc chloride (Aldrich, 99.999%) stock solutions of 1 M, 100 mM, 10 mM, 
and 1 mM were prepared in Millipore water. Stock solutions of 1 mM ligands were prepared in DMSO 
and stored in aliquots at -80 oC. Stock solutions of 40 mM ethylenediamine tetraacetate (EDTA) and 40 
mM N,N,N′,N′-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN) were prepared in DMSO, aliquotted, 
and stored at -20 oC. UV-visible spectra were acquired on a Cary 50-Bio spectrometer using spectrosil 
quartz cuvettes from Starna cells Inc. (3.5 mL volume, 1 cm path length). Acquisitions were made at 
25.00 ± 0.05 oC. Fluorescence spectra were obtained on a Quanta Master 4L-format scanning spectro-
fluorimeter (Photon Technology International) at 25.0 ± 0.1 oC using 1 μM QZ2E or QZ2A unless oth-
erwise noted. All fluorescence experiments were repeated in triplicate.  
Cell Culture and Imaging Materials and Methods. HeLa cells were obtained from American Type 
Cell Collection (ATCC) and cultured in Dulbecco’s Modified Eagle Medium (DMEM, Cellgro, Medi-
aTek, Inc.) supplemented with 10% fetal bovine serum (FBS, PAA Laboratories), 2 mM glutamine 
(GIBCO, Invitrogen), 100 U/mL penicillin (Cellgro, MediaTek, Inc.), and 100 µg/mL streptomycin 
(Cellgro, MediaTek, Inc.). For imaging studies, cells were plated in poly-D-lysine coated plates (Mat-
Tek) containing 2 mL of complete DMEM and incubated overnight at 37 oC under 5% CO2.  
For Zn(II) detection studies, the HeLa cells were incubated with 5 µM QZ2E or QZ2A for ~ 18 h. 
Thirty minutes prior to imaging, the cells were co-incubated with 4.5 µM Hoechst 33258 (Sigma), and 
either 200 nM Mitotracker Red (Invitrogen) or 100 nM BOPIDY TR Ceramide (Invitrogen) for 30 min. 
Cells were washed twice with 1 mL of phosphate buffered saline (PBS, Cellgro, MediaTek, Inc.) before  
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imaging and then bathed in 2 mL of serum-free DMEM during imaging. Stock solutions of 10 mM 
ZnCl2, prepared in Millipore water, and 20 mM sodium pyrithione (2-pyridinethiol-1-oxide), prepared in 
DMSO, were combined in a 1:1 ratio and diluted in serum-free DMEM to a 5 mM stock concentration. 
Zn(II) was added to cells directly on the microscope stage at a final concentration of 100 µM and al-
lowed to incubate with cells for 5 min prior to imaging. Stock solutions of 40 mM ethylenediamine 
tetraacetate ethyl ester (EDTA-(Et)4)42 and 40 mM N,N,N′,N′-tetrakis(-)[(2-pyridylmethyl)]-
ethylenediamine (TPEN) were prepared in DMSO, aliquotted, and stored at -20 oC. Aliquots were 
thawed immediately prior to use and diluted in serum-free DMEM to a 4 mM stock concentration. The 
chelators were added to the cells on the microscope stage at a final concentration of 150 µM for 5 min 
prior to imaging. 
For diffusion studies, HeLa cells were incubated with 5 µM QZ2E for 18 h, with 4.5 µM Hoechst 
33258 added 30 min prior to imaging for nuclear staining. Cells were washed twice with 1 mL of PBS 
prior to imaging and then bathed in 2 mL of serum-free DMEM during imaging. To mimic media flow, 
the serum-free DMEM was removed, and the cells were washed three times with 1 mL of fresh serum-
free DMEM and then bathed in 2 mL of fresh serum-free DMEM. This process was repeated every 10 
min during imaging.  
Images were acquired on a Zeiss Axiovert 200M inverted epifluorescence microscope equipped with 
an EM-CCD digital camera (Hamamatsu) and a MS200 XY Piezo Z stage (Applied Scientific Instru-
ments), illuminated by an X-Cite 120 metal-halide lamp (EXFO). Plates were maintained on the micro-
scope stage in an INC-2000 incubator kept at 37 oC under 5% CO2. Differential interference contrast 
(DIC) and red, blue, and green fluorescent images were obtained using an oil immersion 63x objective 
lens, with 2.00 s exposure times for green fluorescent images. The microscope was operated with Vo-
locity software (Improvision). All fluorescent images were corrected for background. 
Cytotoxicity Assays. HeLa cells were seeded into 96-well plates (100 µL total volume/well, 2500 
cells/well) in complete DMEM and incubated at 37 oC under 5% CO2 for 24 h. The medium was re- 
 
  9 
placed and the cells incubated with QZ2E (1 µM – 50 µM, with an untreated control lane and a 5% 
DMSO in complete DMEM lane) for another 24 h. The medium was removed and replaced with 200 µL 
of a 20:1 mixture of FBS-free DMEM and (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT, 5 mg/mL stock in PBS). The cells were incubated for 4 h and then the medium was re-
moved and replaced with DMSO (100 µL/well). The absorbance of each well was recorded at 555 nm 
on a microplate reader (BioTek, Synergy HT) and the percent cell survival values are reported relative 
to those of untreated control cells. 
 
Results and Discussion 
Design Considerations. The new trappable Zn(II) probes were based on the QZ2 scaffold, because 
this ligand offers many advantages as a Zn(II) detector.25 Firstly, it employs fluorescein as the reporter, 
which imparts good sensing characteristics (vide supra). Secondly, QZ2 detects Zn(II) with av ~ 150-
fold dynamic range, and is selective for Zn(II) over most biologically relevant cations, toxic heavy met-
als, and first-row transition metal ions, with the exception of Cu(II) and Ni(II), neither of which is avail-
able as a mobile M(II) species at high concentrations in vivo. Lastly, QZ2 is capable of detecting Zn(II) 
using one- and two-photon fluorescence microscopy in live cells, where it reports variable fluorescence 
over a wide range of Zn(II) concentrations. Importantly, the low binding affinity of QZ2 (dissociation 
constant Kd1 = 41 ± 3 μM)25 relative to other Zn(II)-specific probes such as ZP1 (Kd1 = 0.04 pM, Kd2 = 
1.2 nM)39 make QZ-type probes suitable for in vivo imaging under conditions of high zinc levels, such 
as in synaptic clefts during neurotransmission in the hippocampus43,44 or from the pancreatic beta cells 
during insulin secretion,45 where it is estimated that labile Zn(II) concentrations may approach millimo-
lar concentrations. Because QZ2 binds Zn(II) with a micromolar dissociation constant and its fluores-
cence does not saturate until millimolar concentrations of Zn(II) are present, QZ2 Zn(II) binding and 
subsequent fluorescence enhancement should be reversible under these physiological conditions, mak- 
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ing the probe particularly suitable for in vivo imaging. 
To impart cell-trappability to QZ2, esters were incorporated onto the quinoline rings. Esters maintain 
cell permeability until the probe is internalized by cells, where intracellular esterases hydrolyze the sub-
stituents to negatively charged carboxylates. The two negative charges on the probe scaffold make 
QZ2E incapable of re-crossing the cell membrane, rendering it cell-trappable. 
Synthesis. The synthetic routes to QZ2E and QZ2A are presented in Scheme 1. 6-Hydroxy-8-
nitroquinoline, 1, was prepared in low yield by the Skraup-Doebner-von Miller reaction between ac-
rolein and 4-amino-3-nitrophenol. Esterification of the quinoline using ethyl bromoacetate and Hünig’s 
base, followed by reduction of the nitro group by hydrogenation with palladium on carbon afforded 
ethyl[(8-aminoquinolin-6-yloxy)acetate], 2, in moderate yield. Condensation of the aminoquinoline with 
4′,5′-fluoresceindicarboxaldehyde22 in methanol followed by reduction of the imine using sodium boro-
hydride resulted in product formation. Purification by column chromatography on silica afforded the 
trappable ligand, QZ2E, 3, in fair yield. Subsequent hydrolysis of QZ2E using aqueous sodium hydrox-
ide in methanol and precipitation with acid afforded the cell-impermeable ligand, QZ2A, 4, in moderate 
yield without the need for further purification. 
Scheme 1. Syntheses of QZ2E and QZ2A. 
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Spectroscopic Properties of QZ2E and QZ2A. QZ2E and QZ2A exhibit spectroscopic features 
similar to those of QZ2 (Table 1).25 The absorbance spectral maxima occur at 499 nm for QZ2E (ε = 
2.72 ± 0.09 x 104 M-1cm-1) with a shoulder at 467 nm (ε = 1.2 ± 0.2 x 104 M-1cm-1), and at 498 nm for 
QZ2A (ε = 6.41 ± 0.03 x 104 M-1cm-1) with a shoulder at 464 nm (ε = 2.49 ± 0.2 x 104 M-1cm-1). Upon 
addition of excess ZnCl2, the maximum absorbance shifts hypsochromically to 489 nm, 496 nm, and 
492 nm (ε = 3.36 x 104 M-1cm-1, ε = 1.6 ± 0.3 x 104 M-1cm-1, and ε = 4.0 ± 0.2 x 104 M-1cm-1 for QZ2, 
QZ2E, and QZ2A, respectively) (Fig. S1). This blue-shift is typical for metal coordination by fluo-
rescein-based sensors and is presumably caused by perturbation of the fluorescein π-system upon cation 
binding to the phenolic oxygen atoms of the xanthenone ring.  
Esterified ligands get hydrolyzed during studies of their pH-dependent properties. We therefore did 
not attempt to measure the pKa values of QZ2E. The pKa of the secondary amine nitrogen atom of QZ2 
is 7.0,25 and an NO probe with a similar structure, FL2,46 has the same pKa value. Because of this simi-
larity, it is likely that QZ2A and FL2A have comparable pKa values (pKa FL2A = 5.9). For QZ2, FL2, 
and FL2A, protonation causes only an ~ 2-fold increase in fluorescence, indicating that the ligands are 
fairly insensitive to pH in the biologically relevant range, especially by comparison to Zn(II)- or NO-
promoted turn-on. 
Metal binding of QZ2E and QZ2A. The emission profiles of QZ2E and QZ2A are almost identical 
to that of QZ2. The emission maxima and quantum yields of the free ligands are given in Table 1. Buff-
a Measurements were performed in 50 mM PIPES, 100 mM KCl at pH 7.0. b Referenced to fluo-
rescein (φ = 0.95 in 0.1 N NaOH). c 20 mM ZnCl2 was added. d DR is the dynamic range, INO/Io. 
 
Table 1. Photophysical properties QZ2, QZ2E, and QZ2A. 
 
 Absorbance λ (nm), ε x 104 (M-1cm-1) 
Emission 
λ (nm), φ (%)b   
   unbound Zn(II) unbound Zn(II)c DRd ref 
QZ2a 499, 3.72 489, 3.36 ~ 520, 0.5 518, 70 ~ 150 23 
QZ2E 499, 2.72(9) 496, 1.6(3) 519, 0.4(1) 514, 73(3) 120(10) this work 
QZ2A 498, 6.41(3) 492, 4.0(2) 515, 1.2(1) 515, 51(1) 30(7) this work 
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ered solutions of QZ2E exhibit significant fluorescence enhancements when treated with excess ZnCl2, 
leading to a 120 ± 10-fold increase in integrated emission upon saturation and a quantum yield increase 
to 73% (Fig. 2a, Table 1). By comparison, addition of excess Zn(II) to QZ2 causes an ~ 150-fold in-
crease in integrated emission and a quantum yield increase to 70%. The differences in fluorescent dy-
namic range can be accounted for by the difference in molar absorptivities of the two ligands. Compar-
ing the product of the molar absoprtivity and quantum yield (ε x φ) of QZ2E (~ 114 M-1cm-1 in the off-
state, ~ 11680 M-1cm-1 in the on-state) with that of QZ2 (~ 186 M-1cm-1 in the off-state, ~ 23520 M-1cm-1 
in the on-state) yields dynamic ranges ((ε x φ) on/(ε x φ) off) of ~ 102 and ~ 126, respectively. The dy-
namic ranges observed by fluorescence (~ 120 and ~ 150, respectively) are larger, but the ratio of the 
dynamic range of QZ2E to that of QZ2 is ~ 0.8 using either (ε x φ) or fluorescence emission. Therefore, 
the difference observed is accounted for by the differences in molar absorptivities. Despite the slight 
lowering of dynamic range upon esterification of the quinoline, an ~ 120-fold change in fluorescence 
intensity is still much greater than that exhibited by Zn(II) sensors of the ZP family19 and more than 
adequate for cellular imaging. Hydrolysis of QZ2E to QZ2A causes a significant reduction in dynamic 
range upon exposure to excess Zn(II) (30 ± 7-fold increase in integrated emission, Fig. 2b) because both 
Figure 2. Normalized fluorescence response in the presence of excess ZnCl2 of a) 1 µM QZ2E, 0 – 20 
mM ZnCl2 and b) 1 µM QZ2A, 0 – 1 mM ZnCl2 in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 oC.  
Insets: Integrated fluorescence vs. ZnCl2 concentration, normalized and adjusted for the basal fluores-
cence of the sensor in the absence of Zn(II). 
a b 
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the molar absorptivity and quantum yield of apo-QZ2A are significantly higher that those of either QZ2 
or QZ2E. The quantum yield of the Zn(II)-saturated QZ2A is also lowered to 51% versus ~ 70% for 
QZ2 and QZ2E; however, a 30-fold turn-on is significantly greater than that of many useful Zn(II)-
specific probes such as ZP1,22 and is more than sufficient for live-cell imaging. 
The strength of Zn(II) binding by a probe is an important feature that determines its use under specific 
biological conditions. Because biological mobile Zn(II) concentrations vary widely depending on loca-
tion and physiological events, it is essential to have fluorescent sensors with a wide array of dissociation 
constants for Zn(II) in order to ensure reversible detection without probe saturation. As discussed in the 
design considerations, the QZ-type probes are weak Zn(II) binders, with Kd values in the micromolar 
range.25 This affinity holds true for QZ2E, which requires millimolar Zn(II) for saturation of the fluores-
cence emission. The strength of QZ2E Zn(II) binding was determined by fitting the fluorescence data to 
a two-site model according to eq 1, where [Zn(II)] is the concentration of free Zn(II) corrected for dilu-
tion, [QZ2E]t is the total concentration of the probe corrected for dilution, Ka1 and Ka2 are the association 
constants for the reactions in eqs 2 and 3, respectively, and I1, I2, and I3 are the proportionality constants 
[QZ2E]t(I1+I2Ka1[Zn(II)]+I3Ka1Ka2[Zn(II)]2)
(1+Ka1[Zn(II)]+Ka1Ka2[Zn(II)]2)
F =  (1) 
 
(5) [QZ2E]t = [QZ2E] + [QZ2E(Zn(II))] + [QZ2E(Zn(II)2]
(2) QZ2E + Zn(II)                    QZ2E(Zn(II)) ,Ka1 Ka1 =                             = 1/Kd2
[QZ2E(Zn(II))]
[QZ2E][Zn(II)]
              
(4) F = I1[QZ2E] + I2[QZ2E(Zn(II))] + I3[QZ2E(Zn(II)2]
(3) 
QZ2E(Zn(II)) + Zn(II)                    QZ2E(Zn(II))2 ,
Ka2 Ka2 =                                         = 1/Kd1
[QZ2E(Zn(II))2]
[QZ2E(Zn(II))][Zn(II)]
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that account for the relative contributions of each QZ2E species to the overall fluorescence emission, 
according to eq 4 (Fig. 2, inset). Eq 1 was determined by substituting into eq 4, using eqs 2, 3, and 5. 
Because the binding of Zn(II) by QZ2E is weak, [Zn(II)] can be approximated by [Zn(II)]t, the total 
concentration of Zn(II) corrected for dilution. Applying the fit to the normalized fluorescence data 
yields values of Ka1 = 7000 ± 5000 M and Ka2 = 287 ± 8 M. Substituting into eqs 2 and 3 yields dissocia-
tions constants of Kd1 = 3.5 ± 0.1 mM (from Ka2) and Kd2 = 150 ± 100 µM (from Ka1). The large error as-
sociated with the Ka1 determination is probably due to the small changes in fluorescence intensity ob-
served upon coordination of the first Zn(II) equivalent (Fig. S2a, micromolar region), a postulate sub-
stantiated by the fact that the second proportionality constant, I2, is similar to the first (I1 = 1.1 ± 0.3 x 
104, I2 = 3 ± 4 x 104) and that this value is subject to a large error. On the other hand, the large fluores-
cence changes associated with the second binding event (I3 = 1.44 ± 0.01 x 106, Fig. S2a, millimolar re-
gion) allow for a more precise estimation of Ka2. It is useful to note that the order of magnitude of bind-
ing, ~ 100 µM, is of the same order as that estimated for QZ2. The Kd1 value for QZ2 was determined by 
taking kinetic data measured by stopped-flow spectroscopy and fitting it to a one-site binding model, 
assuming that the second Zn(II) binding event is of significantly lower affinity. When the fluorescence 
data obtained for QZ2E were fit to a one-site model (eq 6), the Kd value was 2.9 mM, suggesting that the 
second binding event is responsible for most of the fluorescence enhancement. The poor data fit, how-
ever, indicates that a one-site model is inadequate to describe the system (Fig. S2b). 
When the same analysis was repeated for QZ2A using the two-site model, the data could not be fit 
within a reasonable degree of error (Kd1 = 2 mM ± 9 mM, Kd2 = 400 µM ± 300 µM, Fig. S3a). A three-
site model was therefore employed, as described by eq 7, because a similar ligand diacid such as one in 
(6)  
F - F0 =
[QZ2E]t(I2-I1)[Zn(II)]
Kd + [Zn(II)]
[QZ2E]t(I1+I2Ka1[Zn(II)]+I3Ka1Ka2[Zn(II)]2+I4Ka1Ka2Ka3[Zn(II)]3)
(1+Ka1[Zn(II)]+Ka1Ka2[Zn(II)]2+Ka1Ka2Ka3[Zn(II)]3)
F = (7)  
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the Cu(II)-binding NO probe FL2A binds a third metal cation.47 Fitting the fluorescence data for QZ2A 
to eq 7 gave three values of Kd1 = 220 ± 30 µM, Kd2 = 160 ± 80 µM, and Kd3 = 9 ± 6 µM, all of which 
have a significant error, but the result was much better than that afforded by a two-site model (Fig. S3b). 
Most importantly, although Zn(II) binding strength to the quinoline pockets cannot be distinguished 
from Zn(II) affinity for the diacids, all Kd values are around the same order of magnitude as that of 
QZ2E (~ 100 µM) and appropriate for reversible Zn(II) sensing at physiological concentrations.  
   Finally, because of the micromolar to millimolar affinity of QZ2E and QZ2A for Zn(II), it was ex-
Figure 3. a) Normalized fluorescence response of 1 µM QZ2E to 100 µM TPEN after fluorescence is 
elicited by addition of 100 µM ZnCl2, b) 1 µM QZ2E to 100 µM EDTA after fluorescence is elicited by 
addition of 100 µM ZnCl2, c) 1 µM QZ2A to 100 µM TPEN after fluorescence is elicited by addition 
of 100 µM ZnCl2, and d) 1 µM QZ2A to 100 µM EDTA after fluorescence is elicited by addition of 
100 µM ZnCl2. 
0
0.2
0.4
0.6
0.8
1
1.2
480 500 520 540 560 580 600 620 640
1 µM QZ2E
+ 100 µM Zn(II)
+ 100 µM TPEN
No
rm
ali
ze
d 
Em
iss
ion
 (A
U)
Wavelength (nm)
0
0.2
0.4
0.6
0.8
1
1.2
480 500 520 540 560 580 600 620 640
1 µM QZ2E
+ 100 µM Zn(II)
+ 100 µM EDTA
No
rm
ali
ze
d 
Em
iss
ion
 (A
U)
Wavelength (nm)
0
0.2
0.4
0.6
0.8
1
1.2
480 500 520 540 560 580 600 620 640
1 µM QZ2A
+ 100 µM Zn(II)
+ 100 µM TPEN
No
rm
ali
ze
d 
Em
iss
ion
 (A
U)
Wavelength (nm)
0
0.2
0.4
0.6
0.8
1
1.2
480 500 520 540 560 580 600 620 640
1 µM QZ2A
+ 100 µM Zn(II)
+ 100 µM EDTA
No
rm
ali
ze
d 
Em
iss
ion
 (A
U)
Wavelength (nm)
a b 
c d 
  16 
pected that, like QZ2, their Zn(II)-induced fluorescence would be readily reversed by the Zn(II) chelator 
TPEN (Kd = 10-15.6 M).48 When 100 µM ZnCl2 was added to a 1 µM solution of QZ2E, however, the re-
sulting fluorescence was bearly affected by the addition of 100 µM TPEN (Fig. 3a). When the same ex-
periment was repeated using EDTA (Kd = 10-16.4 M)48 as the Zn(II) chelator, the fluorescence was dimin-
ished to near baseline levels (Fig. 3b). Repeating the experiment with tripicolylamine (TPA) vs diethyl-
enetriaminepentaacetic acid (DTPA, Kd = 10-18.7 M)48 gave similar results (data not shown). It is unlikely 
that TPEN and TPA are incapable of chelating Zn(II), given their superior affinity for the metal ion over 
QZ2E. The basic, pyridyl-based chelators seemingly interact with QZ2E to elicit a fluorescence re-
sponse by a different, unknown mechanism. Because esterification of the quinoline rings of QZ2E pre-
sumably bends the quinolines out of plane with respect to the fluorescein to avoid a steric clash, it is 
possible that the Zn(II)-binding pocket of QZ2E is different from that of QZ2. We hypothesize that in-
stead of chelating Zn(II), the pyridine rings of TPEN form a complex with Zn(II)-bound QZ2E, thereby 
stabilizing a fluorescent species. By comparison, the Zn(II)-induced fluorescence of QZ2A is fully re-
versed by both TPEN and EDTA (Fig. 3c, d), suggesting that removal of the ethyl groups is sufficient to 
relieve the purported steric clash. Because an effective chelator (EDTA) was found for QZ2E, TPEN 
binding was not further pursued. 
Selectivity of QZ2E and QZ2A for Zn(II). In order for a probe to be useful for cellular detection of 
an analyte, it must be specific for that analyte over other competing biologically relevant species. One 
advantage of the QZ scaffold over the ZP scaffold is that, although the dipicolylamine chelating unit of 
the ZP family binds Zn(II) very tightly, it is not as specific for Zn(II) compared to the aminoquinoline 
Zn(II)-binding unit of QZ2.19,25 Both families of sensors are specific for Zn(II) over the biologically rele-
vant Na(I), Ca(II), and Mg(II), the first row transition element Mn(II), and the toxic heavy metals Hg(II) 
and Cd(II). The QZ family, however, is also selective for Zn(II) over Fe(II) and Co(II).25 We therefore 
performed a fluorescence selectivity study to ensure that modification of the quinoline ring did  
not alter the metal binding properties of QZ2E or QZ2A significantly enough to affect its selectivity 
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(Fig. 4). As anticipated, Zn(II) can displace from the new probes all the metal ions tested except for 
Ni(II) and Cu(II), in agreement with the selectivity shown by QZ2, confirming that modification of the 
quinoline ring does not alter metal-binding selectivity. 
Zn(II) Detection in Live Cells. The ability of QZ2E to detect Zn(II) in live cells was investigated us-
ing pyrithione as an ionophore to load the metal ion into cells. HeLa cells were incubated with 5 µM 
QZ2E for 18 h (Fig. 5); 4.5 µM Hoechst 33258 was added 30 min prior to imaging to stain the cell nu-
clei (Fig. 5b). Very little background fluorescence was observed (Fig. 5c) in the absence of Zn(II), but 
upon addition of a physiologically relevant concentration of 100 µM Zn:pyrithione (1:1), an immediate 
increase in fluorescence occurred that maximized within 5 min (Fig. 5d). To ensure that Zn(II) binding 
of QZ2E induced this fluorescence response, EDTA-(Et)4, a cell-permeable variant of EDTA, was incu-
bated with the cells. For EDTA-(Et)4-induced Zn(II) chelation, and therefore reduction in fluorescence 
signal to occur, the ester moieties of the chelator must be hydrolyzed intracellularly. Addition of 150 
µM EDTA-(Et)4 did not cause an immediate reduction of fluorescence, but after an ~ 5 min incubation 
period the fluorescence in the green channel was reduced nearly to background levels (Fig. 5e). This 
Figure 4. Selectivity of a) QZ2E and b) QZ2A for Zn(II) compared to Na(I), Ca(II), Mg(II), Mn(II), 
Fe(II), Co(II), Ni(II), Cu(II), Cd(II), and Hg(II). Normalized fluorescence response relative to the emis-
sion of QZ2E in 50 mM PIPES, 100 mM KCl, pH 7.0, T = 25 oC. 
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result demonstrates that the observed fluorescence is Zn(II)-dependent. A longer incubation period of 
EDTA-(Et)4 would presumably lead to complete hydrolysis of the chelator and therefore complete re-
duction of the fluorescence signal in the green channel; however, both the chelator and the ethanol by-
product of hydrolysis are toxic to cells, and longer EDTA-(Et)4 incubation periods resulted in cell death. 
Cell-Trappability of QZ2E. To demonstrate trappability of the probe, HeLa cells were incubated 
with 5 µM QZ2E for ~ 18 h to ensure sufficient time for hydrolysis of the ester moieties to produce the 
cell-impermeable acids (Fig. 6). Addition of 4.5 µM Hoechst 33258 30 min prior to imaging was used 
to stain the cell nuclei (Fig. 6b). Addition of 100 µM Zn(II):pyrithione (1:1) resulted in a change in fluo-
Figure 5. HeLa cells co-incubated with 5 µM QZ2E, and 4.5 µM Hoechst 33258 for 18 h. a) DIC im-
age, b) emission from the blue channel (nuclear stain), c) emission from the green channel (Zn(II) 
probe), d) emission from the green channel after addition of 100 µM Zn:pyrithione (1:1), and e) emis-
sion from the green channel after addition of 150 µM EDTA-(Et)4. Scale bars 25 μm. 
 
 
Figure 6. Cell imaging experiments demonstrating retention of QZ2E in HeLa cells co-incubated 
with 5 µM QZ2E, and 4.5 µM Hoechst 33258 for 18 h. a) DIC image, b) emission from the blue 
channel (nuclear stain), c) emission from the green channel (Zn(II) probe), d emission from the green 
channel after addition of 100 µM Zn:pyrithione (1:1) at 5 min, e) 15 min, f) 25 min, g) 35 min, and 
h) 45 min. Scale bars 25 μm. 
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rescence from background levels (Fig 6c) to bright green (Fig. 6d) within 5 min. During this time and 
throughout the experiment, cells were maintained in a microscope incubator at 37 oC under 5% CO2 to 
preserve cell viability. Over the course of 45 min, the cells were periodically washed to mimic condi-
tions of media perfusion. The serum-free DMEM bath was carefully removed by pipette while the plate 
remained on the microscope and then fresh serum-free DMEM was added. The serum-free DMEM was 
removed and replaced three times to ensure good washing of the cells, and then removed permanently 
and replaced with 2 mL of fresh serum-free DMEM. Imaging every 10 minutes over the course of the 
experiment (Fig. 6e – h) revealed that, under these conditions, Q2E is retained in HeLa cells. 
As a further demonstration of cell-trappability, HeLa cells were loaded with 5 µM QZ2A for ~ 18 h 
with 4.5 µM Hoechst 33258 applied 30 min prior to imaging. Upon washing the cells and imaging, no 
fluorescent signal was present before or after Zn(II):pyrithione (1;1) addition (Fig. S4). This result is 
consistent with the hypothesis that the negative charges of the deprotonated carboxylates would prevent 
QZ2A from entering cells. 
QZ2E Localization in HeLa Cells. Like many other fluorescein-based probes, QZ2E shows localiza-
tion patterns in live cells.27,47 Punctate staining was observed with clustering in the region surrounding 
the nuclei, suggesting that QZ2E subcellularly localizes in HeLa cells. To test this hypothesis and de-
termine the organelle of localization, HeLa cells were first coincubated with QZ2E (5 µM), Hoechst 
33258 (4.5 µM, nuclear stain), and Mitotracker Red (200 nM, mitochondrial stain), because a probe 
with a similar structure, Cu2(FL2E), localizes to mitochondria in SK-N-SH cells.47 Zn(II):pyrithione 
(100 µM, 1:1) was added because the green fluorescence could not be visualized adequately without 
inducing fluorescence enhancement. The results are illustrated in Figs. 7a – e. QZ2E does not enter the 
nucleus (Fig. 7b, c), as expected, because the negatively charged acids produced upon esterase cleavage 
of the esters should block passage across the nuclear membrane. An overlay of the green probe fluores-
cence (Fig. 7c) and the red mitochondrial stain fluorescence (Fig. 7d) indicates very little overlap (Fig. 
7e). Most of the red fluorescence persists in the overlay except for a small region of yellow immediately 
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surrounding the nucleus. These data are inconsistent with QZ2E localization to mitochondria. 
The Golgi apparatus is another subcellular compartment to which fluorescein-based probes can local-
ize,27 and is located in close proximity to the nucleus. Therefore, the localization experiments were re-
peated by incubating HeLa cells with QZ2E (5 µM), Hoechst 33258 (4.5 µM, nuclear stain), and 
BODIPY TR Ceramide (100 nM, Golgi apparatus stain), and then inducing adequate green fluorescence 
for visualization with Zn(II):pyrithione (100 µM, 1:1, Fig. 8a – e). In contrast to the results of the mito-
chondrial staining experiment, an overlay of the green probe fluorescence (Fig. 8c) and the red Golgi 
stain fluorescence (Fig. 8d) revealed excellent colocalization (Fig. 8e). Essentially all of the red fluores-
cence observed in Fig, 8d appeared yellow when overlayed with the green QZ2E fluorescence, indicat-
ing that QZ2E localizes subcellularly to the Golgi apparatus in HeLa cells. The small overlap of green 
and red fluorescence observed in Fig. 7e is probably due to mitochondrial and Golgi overlap along the 
z-axis of the cell and not true localization of QZ2E to mitochondria. 
Figure 7. HeLa cells co-incubated with 5 µM QZ2E, 4.5 µM Hoechst 33258, and 200 nM Mitotracker 
red for 18 h. a) DIC image, b) emission from the blue channel (nuclear stain), c) emission from the 
green channel (Zn(II) probe) after addition of 100 µM Zn:pyrithione (1:1), d) emission from the red 
channel (mitochondrial stain), e) overlay of the green and red channels. Scale bars 25 μm. 
Figure 8. HeLa cells co-incubated with 5 µM QZ2E, 4.5 µM Hoechst 33258, and 100 nM BODIPY 
TR Ceramide for 18 h. a) DIC image, b) emission from the blue channel (nuclear stain), c) emission 
from the green channel (Zn(II) probe) after addition of 100 µM Zn:pyrithione (1:1), d) emission from 
the red channel (Golgi aparatus stain), e) overlay of the green and red channels. Scale bars 25 μm. 
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Cytotoxicity of QZ2E. Over the course of the cell imaging experiments, there was no visual cell 
death caused by QZ2E at the concentration used (5 µM); however, the experiments were performed at 
low probe concentration. To investigate the potential cytotoxic effects of QZ2E at higher concentra-
tions, which may be needed for certain biological applications such as in tissue slices,47 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays49 were performed over a 24 hour 
period. The results indicate that QZ2E is minimally cytotoxic to HeLa cells at concentrations under 25 
µM, with ~ 85% cell survival over 24 h for 1 µM probe loading, and ~ 70% cell survival over 24 h for 
10 µM QZ2E. At higher concentrations, the probe becomes more toxic. For example, at 25 µM QZ2E 
the cell survival over 24 h drops to ~ 50%. The cytotoxicity assays are limited by the insolubility of 
QZ2E in DMSO. Incubation of HeLa cells with 50 µM QZ2E requires a 5% loading of DMSO, which is 
itself toxic, and therefore cell survival at this concentration over 24 h was only ~ 30%. A control incuba-
tion with 5% DMSO and no QZ2E showed similar results (~ 20% cell survival over 24 h), confirming 
that the addition of DMSO associated with QZ2E application is a limiting factor in QZ2E cytotoxicity. 
 
Summary 
The synthesis and spectroscopic characterization of the cell-trappable, fluorescein-based Zn(II) probe 
QZ2E and its cell-impermeable couterpart, QZ2A, are described. Modifications of the quinoline ring of 
QZ2E and QZ2A do not drastically alter the Zn(II) binding capacities of the probes when compared to 
the first generation probe, QZ2 (Kd1 (QZ2) = 41 ± 3 μM, Kd1 (QZ2E) = 3.5 ± 0.6 mM, Kd2 (QZ2E) = 150 
± 100 µM, Kd1 (QZ2A) = 220 ± 30 µM, Kd2 (QZ2A) = 160 ± 80 µM, Kd3 (QZ2A) = 9 ± 6 µM), nor are 
their emissive properties altered before and after ZnCl2 addition to buffered solutions (φ (QZ2) = 0.5%, 
φ (QZ2 + Zn(II)) = 70%; φ (QZ2E) = 0.4 ± 0.1%, φ (QZ2E + Zn(II)) = 73 ± 3%; φ (QZ2A) = 1.2 ± 
0.1%, φ (QZ2A + Zn(II)) = 51 ± 1%). QZ2E has a slightly reduced dynamic range with respect to QZ2, 
~ 120-fold enhancement versus ~ 150-fold enhancement, respectively, but maintains selectivity for 
Zn(II) over other biologically relevant cations, toxic heavy metals, and most first-row transition metal 
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ions. The dynamic range of QZ2A is more significantly reduced, to ~ 30-fold enhancement, but this 
value is more than adequate for in vivo visualization. QZ2E is a competent Zn(II) sensor in live HeLa 
cells and is retained intracellularly despite numerous washings. Unlike QZ2, QZ2E localizes to the 
Golgi apparatus in HeLa cells, a difference that may reflect its greater negative charge following intra-
cellular hydrolysis of its ester moieties to become QZ2A. 
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TOC Graphic: The trappable Zn(II) fluorescent probe, QZ2E, enters cells where it is hydrolyzed by 
esterases to form cell-impermeable QZ2A. Following exposure of QZ2A to Zn(II), there is an approxi-
mately 30-fold fluorescence enhancement. 
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